Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that while some organisms can regenerate body parts, mammals generally cannot, and cancer progression is complex, involving mutations rather than a strict stem cell hierarchy.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Fasting may reduce chemotherapy side effects.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Early balding at 40 increases prostate cancer risk.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Cancer treatments often cause hair loss, and more research is needed to prevent and treat it.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Cancer survivors need better skin care to improve their quality of life.

Pancreatic cancer pain management is inadequate due to the disease's severity and limited effectiveness of treatments.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Certain microRNAs found in normal cells can effectively suppress various cancers.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.